University of Liverpool

Synthetic Teixobactins: multi-targeting super antibiotics to combat superbugs 

The University of Liverpool have pioneered the designs and synthesis of a new class of antibiotics. Our synthesis platform is robust, automated, and scalable and uses low-cost goods. Synthetic teixobactins kill resistant bacterial pathogens without detectable resistance and have the potential to provide new treatment options to save countless lives globally.



2024 finalists

Take a look at the finalists across the four competition categories